Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nab-paclitaxel”

674 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 674 results

Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06591650
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer

Who this might be right for
Gallbladder Cancer Unresectable
Fudan University 33
Testing effectiveness (Phase 2)Study completedNCT02879318
What this trial is testing

Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Canadian Cancer Trials Group 180
Large-scale testing (Phase 3)Study completedNCT04083235
What this trial is testing

Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Ipsen 770
Testing effectiveness (Phase 2)Study completedNCT02716038
What this trial is testing

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Columbia University 39
Testing effectiveness (Phase 2)UnknownNCT03779464
What this trial is testing

Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerNab-paclitaxelGemcitabine+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 132
Testing effectiveness (Phase 2)WithdrawnNCT04754815
What this trial is testing

Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Lung Non-Small Cell CarcinomaPD-L1 Gene Mutation
Shirish Gadgeel
Early research (Phase 1)Ended earlyNCT03520790
What this trial is testing

Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 36
Early research (Phase 1)Looking for participantsNCT05685602
What this trial is testing

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT04138719
What this trial is testing

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Who this might be right for
Breast CancerTriple-negative Breast CancerNab-paclitaxel
Hebei Medical University Fourth Hospital 520
Testing effectiveness (Phase 2)UnknownNCT04692051
What this trial is testing

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Huazhong University of Science and Technology 100
Testing effectiveness (Phase 2)UnknownNCT02215447
What this trial is testing

A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas

Who this might be right for
Gastrointestinal Neuroendocrine Carcinomas
Barwon Health 4
Early research (Phase 1)Study completedNCT00307255
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Testing effectiveness (Phase 2)Active Not RecruitingNCT02270814
What this trial is testing

Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaCancer of the Head and Neck
Washington University School of Medicine 74
Testing effectiveness (Phase 2)Study completedNCT03289819
What this trial is testing

Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC

Who this might be right for
Malignant Neoplasm of Breast
Institut fuer Frauengesundheit 53
Testing effectiveness (Phase 2)Study completedNCT04004871
What this trial is testing

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharynx Cancer
Guangxi Medical University 60
Large-scale testing (Phase 3)Looking for participantsNCT05254171
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV
Panbela Therapeutics, Inc. 600
Early research (Phase 1)Ended earlyNCT02267707
What this trial is testing

Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia

Who this might be right for
Pancreatic NeoplasmsCholestasis
Celgene 1
Testing effectiveness (Phase 2)Study completedNCT03464734
What this trial is testing

Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 70
Load More Results